AM 2023 banner   be part of it




Overview :: Program Book :: Floorplan :: Poster Table

Program Overview

Updated: 08.08.2023

OEGMBT AM23 OverviewGrid 08.08.23

Program Book

Updated: 15.09.2023 A printed version of this Programbook with the detailed program will be handed out to all participants during the onsite registration. A PDF version of the programbook is also available for download here:
ÖGMBT JT2023 Program book Cover minif

Abstract Book

Please note that to save paper the full Abstractbook with all abstracts and particpants list is only available online as PDF to registered participants after login to the registration system.

Poster Table:

Latest Update 13.9.23: Late Posters added

Download the Poster table as a PDF.

Floor plan

OEGMBT VenuePlan AM23 A3 v4 2

Tue 19.9.

Latest Update 13.9.23: Speaker and Chair updates

Tuesday, September 19th, 2023

11:00 - 12:10

Opening Ceremony

Moderation: Viktoria Weber (ÖGMBT President, Danube University Krems, AT)

Laudatio for Josef Glößl (former ÖGMBT President)

11:15 - 12:10

Life Science Awards Austria 2023

Moderation: Viktoria Weber (ÖGMBT President, Danube University Krems, AT)




THP Logo


Life Science PhD Award Austria 2023 – Basic Science

LS-ST01 - Alexander Hanzl (FMI Friedrich Miescher Institute for Biomedical Research, CH) Alexander Hanzl

Identifying novel degraders and resistance mechanisms in targeted protein degradation.

 Polymun 300px

Life Science PhD Award Austria 2023 – Applied Research

LS-ST02 - Matthias Hinterndorfer (CeMM Center for Molecular Medicine, AT) Matthias Hinterndorfer

Time-resolved genetic screens to dissect gene functions and regulatory networks






Opening words by Ulrike Unterer (BMAW, AT)

Research Award winners: Johanna Gassler, David Hoi & Klemens Kremser

Award winners will present their work during the RISING STAR LECTURES session on Sept. 20th at 9:00

12:10 - 12:30

Science flash session 1


Silja Weßler University of Salzburg, AT


SF1-SF01 - Noopur Dubey (Institute of Molecular Biosciences, AT)

Identification of the inhibitor binding sites in the toxin protein ExoU secreted by Pseudomonas aeruginosa


SF1-SF02 - Bruno Benedetti (Paracelsus Medical University - Privatstiftung, AT)

Different monoaminergic modulation of resting and activated microglia


SF1-SF03 - Arthur Chinedu Okafor (Austrian Agency for Health and Food Safety, AT)

From Shell to Genome: Assessing Gammaproteobacteria in Edible Snails through Genomic Characterization


SF1-SF04 - Florian Wolff (University of Salzburg, AT)

Effects of hypomethylating agents on purinergic signaling in human AML cell lines


SF1-SF05 - Rupert Klaushofer (Paris Lodron University Salzburg, AT)

Positional scan revealed an optimized consensus peptide for legumain ligase activity


SF1-SF06 - Wai Tuck Soh (Max Planck Institute for Multidisciplinary Sciences, DE)

Identification and characterization of hydrolyzed and spliced peptides catalyzed by human 20S proteasomes


SF1-SF07 - Markus Schosserer (Medical University of Vienna, AT)

Deletion of the RNA methyltransferase Nsun5 reduces frailty in mice


SF1-SF08 - Gerlinde Karbon (Medical University of Innsbruck, AT)

Systemic deregulation of the spindle assembly checkpoint triggers myelosuppression and gastrointestinal atrophy.


SF1-SF09 - Marina Cañadas-Ortega (Paris Lodron University Salzburg, AT)

Helicobacter pylori delivers proteases into gastroids through outer membrane vesicles

12:30 - 13:30

Lunch & Poster Session 1

13:30 - 15:00

Microbiology & immunology


Silja Weßler University of Salzburg, AT

Theresa Neuper University of Salzburg, AT

Monika Ehling-Schulz Vetmeduni Vienna, AT

13:30 - 14:00

LS1-IT01 - Carmen Buchrieser (Institut Pasteur, FR) Carmen Buchrieser

Transkingdom signalling via Legionella pneumophila small regulatory RNAs and extracellular vesicles

14:00 - 14:15

LS1-ST01 - Tom Grunert (Vetmeduni VIenna, AT)

Within-host evolution of Staphylococcus aureus in bovine mastitis

14:15 - 14:30

LS1-ST02 - Jazleena Panikkaveetil Jawaharlal (Institute of Molecular Biosciences, University of Graz, AT)

Identification of M. tuberculosis monoacylglycerol lipase (mtbMGL) inhibitors by crystallographic fragment screening

14:30 - 14:45

LS1-ST03 - Lydia Riepler (Medical University of Innsbruck, AT)

Induction of T cell responses against the human papillomavirus (HPV) in the mouse female genital tract upon immunization with the viral vector VSV-GP

14:45 - 15:00

LS1-ST04 - Tobias Frauenlob (University of Salzburg, AT)

Helicobacter pylori priming of human monocytes induces hyperresponsive activation state via accumulation of NF-кB proteins

13:30 - 15:00

Spatial biology


Dirk Schmidt-Arras Paris-Lodron-University Salzburg, AT

13:30 - 14:00

T1-IT01 - Christian Schürch (University Hospital Tübingen, DE) Christian Schürch

Deconstructing Immune Mechanisms, Therapy Response and Patient Outcomes by High-Multiplex Tumor Imaging

14:00 - 14:15

T1-ST01 - Theresa Neuper (University of Salzburg, AT)

Effects of ADP-heptose on human primary dendritic cells

14:15 - 14:30

T1-ST02 - Fritz Aberger (University of Salzburg, AT)

GLI-YAP interactions in basal cell carcinoma promote immune evasion by regulating the spatial distribution of immune responses

14:30 - 14:45

T1-ST03 - Michael S. Unger (Paris Lodron University Salzburg, AT)

The NLRP3/eIF2 axis promotes leukemic blasts survival and disease progression in acute myeloid leukemia

14:45 - 15:00

T1-ST04 - Mila Basic (Lunaphore Technologies, CH)

 Mapping the tissue composition with hyperplex immunofluorescence on delicate samples

15:00 - 16:00

Coffee Break & Poster Session 1

16:00 - 17:30

Tumor immunology & microenvironment


Fritz Aberger University of Salzburg, AT

Barbara Kofler Department of Pediatrics, University Hospital of the Paracelsus Medical University, AT

16:00 - 16:30

LS2-IT01 - Almut Schulze (DKFZ, DE) Almut Schulze

Targeting Glucose and Lipid Metabolism in Cancer

16:30 - 16:45

LS2-ST01 - Ulrich Elling (Institute of Molecular Biotechnology, AT)

A new CRISPR screening paradigm uncovers genetic dependencies of cancer in vivo

16:45 - 17:00

LS2-ST02 - Bernadette Mödl (Medical University of Vienna, AT)

The Janus kinase Tyk2 prevents colon cancer metastasis

17:00 - 17:15

LS2-ST03 - Josefina Piñon Hofbauer (SALK, AT)

Anti-neoplastic properties of metformin in epidermolysis bullosa associated aggressive cutaneous squamous cell carcinoma

17:15 - 17:30

LS2-ST04 - Daniela Weber (University Hospital of the Paracelsus Medical University, AT)

Integrative omics analysis to elucidate potential antitumor mechanisms of a ketogenic diet in melanoma

16:00 - 17:30

Protein editing & post-translational modifications


Hans Brandstetter University of Salzburg, AT

Elfriede Dall University of Salzburg, AT

16:00 - 16:30

T2-IT01 - Anne C. Conibear (TU Wien, AT) Anne C. Conibear

Chemical biology tools to understand protein posttranslational modifications

16:30 - 16:45

T2-ST01 - Marion Goldeck (Medical Univerity of Vienna, AT)

STOPTACs: Scissile turn-off proteolysis targeting chimeras

16:45 - 17:00

T2-ST02 - Charlotte Zajc (University of Natural Resources and Life Sciences, AT)

Taking control of CAR T cells- engineering of molecular ON-switches for cellular therapies

17:00 - 17:15

T2-ST03 - Esther Schoenauer (University of Salzburg, AT)

The activator domain of bacterial collagenases drives collagen recognition, unwinding and processing.

17:15 - 17:30

T2-ST04 - Qishun Zhou (Medical University of Graz, AT)

Tyrosine-mediated nuclear import of CIRBP reveals an alternative NLS recognition mechanism by TNPO3

17:30 - 18:10

Plenary Session 1


Iris Gratz University of Salzburg, AT

PL1-PL01 - Shruti Naik (NYU Langone Health, US) Shruti Naik

Immune-mediated mechanisms of tissue adaptation and maladaptation

18:15 - 21:00

Wine & Science

Session Description



Wed 20.9.

Latest Update 13.9.23: Speaker and Chair updates

Wednesday, September 20th, 2023

09:00 - 09:40

Plenary Session 2 - Rising Star Lectures


Joachim Seipelt Jury chair, Nuvonis Technologies GmbH, AT




PL2-ST01 - Johanna Gassler (Max Planck Institute of Biochemistry, DE) Johanna Gassler

Zygotic genome activation by the totipotency pioneer factor Nr5a2




PL2-ST02 - David Hoi (Institute of Molecular Pathology, AT) David Hoi

Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival




PL2-ST03 - Klemens Kremser (University of Natural Resources and Life Sciences, Vienna, AT) Klemens Kremser

Bioleaching/enzyme-based recycling of aluminium and polyethylene from beverage cartons packaging waste

09:40 - 10:00

Science flash session 2


Nikolaus Fortelny University of Salzburg, AT


SF2-SF01 - Martin Funk (EVOMEDIS GmbH, AT)

EVOCellic - Lyophilized human keratinocytes as a novel treatment for hard to heal wounds


SF2-SF02 - Sabrina Nebel (University of Natural Resources and Life Sciences BOKU, Vienna, AT)

3D cultivation of adipose-derived mesenchymal stem cells within alginate core–shell capsules


SF2-SF03 - Farhad Chariyev-Prinz (University of Natural Resources and Life Sciences, AT)

Dynamic culturing of Mesenchymal Stem Cells encapsulated in different configurations of Methylcellulose/Gelatin Methacrylate (GelMA) microgels


SF2-SF04 - Martin Hold (University of Vienna, AT)

Development of a genome-scale model tailored to a specific cell-line for a CHO fed-batch process platform


SF2-SF05 - Johannes Stöckelmaier (University of Natural Resources and Life Sciences, Vienna, AT)

Joining GROMOS and MDAnalysis - Investigating solvent dynamics inside the active site


SF2-SF07 - Johannes Lederbauer (Landeskrankenhaus Salzburg, AT)

Novel molecular insights into the DHX30-associated neurodevelopmental disorders


SF2-SF08 - Marta Surbek (Medical University of Vienna, AT)

Modification of transglutaminase-1 during cornification of epidermal keratinocytes


SF2-SF09 - Johannes Bischof (EB House, AT)

Prime Editing as a therapeutic tool for Epidermolysis bullosa

10:00 - 10:30

Coffee Break

10:30 - 12:00

Regenerative medicine & Stem cells


Andreas Traweger Paracelsus Medical University, AT

Ludwig Aigner Paracelsus Medical University Salzburg, AT

10:30 - 11:00

LS3-IT01 - Saul Villeda (University of California San Francisco, US) Saul Villeda

Systemic mechanisms of brain rejuvenation

11:00 - 11:15

LS3-ST01 - Julia Moldaschl (University of Natural Resources and Life Sciences (BOKU), AT)

3D multilineage differentiation model of mesenchymal stem/stromal cells under physiological conditions

11:15 - 11:30

LS3-ST02 - Ilias Nikolits (BOKU, AT)

Effects of different in vitro cultivation conditions on human mesenchymal stem cells encapsulated in TEMPO-oxidized nanofibrillated cellulose hydrogels.

11:30 - 11:45

LS3-ST03 - Marco Zattoni (Paracelsus Medical University, AT)

CXCL16-CXCR6 axis involvement in Alzheimer's disease-specific CD8+T-cells recruitment to the brain

11:45 - 12:00

LS3-ST04 - Christine Lehner (Paracelsus Medical University, AT)

TRP-channels in tendons: a potential therapeutic target?

10:30 - 12:00

Systems & computational biology


Nikolaus Fortelny University of Salzburg, AT

Markus Wiederstein University of Salzburg, AT

10:30 - 11:00

T3-IT01 - Ulrich Stelzl (University of Graz, AT) Ulrich Stelzl

Functional characterization of protein networks through deep mutational protein-interaction perturbation scannin

11:00 - 11:15

T3-ST01 - Gabriel Alexander Vignolle (AIT Austrian Institute of Technology GmbH, AT)

Machine learning empowered prediction of consequences following intraventricular hemorrhage in preterm neonates using targeted proteomics

11:15 - 11:30

T3-ST02 - Lena Parigger (Innophore, AT)

Innophore: Building the protein and drug discovery platform of the future

11:30 - 11:45

T3-ST03 - Tea Kuvek (University of Natural Resources and Life Sciences, AT)

The flexibility and dynamics of binding sites in plant cytochrome P450s

11:45 - 12:00

T3-ST04 - Guido Schlögel (University of Vienna, AT)

Designing an optimal fed-batch process using a comprehensive differential equation model

12:00 - 13:00

Lunch & Poster Session 2

13:00 - 14:30

Rare diseases


Verena Wally EB House Austria, University Hospital for Dermatology and Allergology, AT

Josefina Piñon Hofbauer SALK, AT

13:00 - 13:30

LS4-IT01 - Alain Hovnanian (INSERM-Imagine Institute, FR) Alain Hovnanian

New insights in Netherton syndrome, Olmsted syndrome and Pachyonychia Congenita : from pathogenesis to therapeutic implications

13:30 - 13:45

LS4-ST01 - Jana Willim (Landesklinikum Salzburg, AT)

Lessel-Kubisch syndrome as a model to decipher the Achilles heel of p53  

13:45 - 14:00

LS4-ST02 - Stefanie Gruner (EB House Austria, AT)

S. aureus isolates established from epidermolysis bullosa patients vary in their virulence and impact on host cells

14:00 - 14:15

LS4-ST03 - Oleksandr Petrenko (Medical University of Vienna, AT)

Elucidation of cell-cell and cell-matrix crosstalk in primary sclerosing cholangitis

14:15 - 14:30

LS4-ST04 - Julia Illmer (EB House Austria, AT)

TGF-β and IL-6 induced epigenetic changes in keratinocytes and fibroblasts of patients with recessive dystrophic epidermolysis bullosa

13:00 - 14:30

Extracellular vesicles & nanomedicine


Nicole Meisner-Kober Paris Lodron University Salzburg, AT

Mark Geppert Paris Lodron University of Salzburg, AT

13:00 - 13:30

T4-IT01 - Sebastian Schwaminger (Medical University of Graz, AT) Sebastian Schwaminger

Versatility of Iron Oxide Nanoparticles for Nanomedicine Applications

13:30 - 13:45

T4-ST01 - Viktoria Weber (University for Continuing Education Krems, AT)

Characterization of tissue factor-bearing extracellular vesicles in COVID-19 provides evidence for platelet-leukocyte aggregate formation

13:45 - 14:00

T4-ST02 - Lucia Ciglar (AIT, AT)

Exploring the landscape of miRNAs in circulating extracellular vesicles of ulcerative colitis mouse models

14:00 - 14:15

T4-ST03 - Gunda Üblagger (Paris Lodron Universität Salzburg, AT)

Helicobacter pylori-derived outer membrane vesicles induce activation of primary human monocytes

14:15 - 14:30

T4-ST04 - Benjamin Punz (PLUS, AT)

Novel antimicrobial surface assay for development of green nanomaterial alternatives

14:30 - 15:30

Coffee Break & Poster Session 2

14:30 - 15:30

Company workshop Lunaphore Technologies

Muge Akpinar (Lunaphore Technologies Inc, CH)

Spatial cell profiling with hyperplex immunofluorescence

15:30 - 16:30

PhD Session


Erica Pelamatti PLUS Universitat Salzburg, AT

Patricia HrasnovaUniversity of Salzburg, AT

15:30 - 15:45

PhD-ST01 - Astha Purwar (Medizinische Universität Innsbruck, AT)

Organelle-specific assembly of the ESCRT machinery and their role in organellar repair

15:45 - 16:00

PhD-ST02 - Florian Sikora (Max Perutz Labs, University of Vienna, AT)

The Escherichia coli rpoN operon is an auxiliary component of the envelope stress response

16:00 - 16:15

PhD-ST03 - Marianne Mießkes (University of Vienna, AT)

Unmasking nature's collaborators: Computing all feasible compositions of microbial communities

16:15 - 16:30

PhD-ST04 - Dino Bekric (Paracelsus Medical University of Salzburg, AT)

Inducing ferroptosis, a new approach to target biliary tract cancer?

15:30 - 16:30

General Assembly

16:40 - 17:20

Plenary Session 3


Nikolaus Fortelny University of Salzburg, AT

PL3-PL01 - Jörg Menche (University of Vienna, AT) Jörg Menche

Network medicine:  From protein-protein to human-machine interactions

18:00 - 22:00

Guided walk & Beer garden

Session Description



Thu 21.9.

Latest Update 13.9.23: Speaker and Chair updates

Thursday, September 21st, 2023

09:00 - 09:40
Sponsored by

Plenary Session 4


Nicole Meisner-Kober Paris Lodron University Salzburg, AT

PL4-PL01 - Pieter Vader (University Medical Center Utrecht, NL) Pieter Vader

Extracellular vesicle-mediated RNA delivery - from mechanistic insights towards therapeutic applications

09:40 - 10:00

Science flash session 3


Nicole Meisner-Kober Paris Lodron University Salzburg, AT


SF3-SF01 - Sophie Große-Kathöfer (University Salzburg, AT)

A dual-reporter mouse model for parallel in vivo screening of Th1 and Th2 responses induced by allergenic pollen extracts


SF3-SF02 - Nicole Ridlmaier (FH Campus Wien, AT)

T cell responses to a-Gal-carrying tick saliva proteins


SF3-SF03 - Alessandro Bellapianta (Johannes Kepler Universität, AT)

hiPSCs- derived Retinal Organoids as a model system for Organic Retinal Prosthesis


SF3-SF04 - Lena Schreiberhuber (University of Innsbruck, AT)

The WID-qEC test: performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancers


SF3-SF05 - Luca Catalano (University Hospital Salzburg, AT)

Triple treatment with low-dose cyclophosphamide, ketogenic diet and metformin induces distinct changes in the transcriptome of neuroblastoma xenografts


SF3-SF06 - Rotraud Hirschberger (Medical University of Innsbruck, AT)

Exploring potential interaction partners of the dual-adapter protein RAIDD


SF3-SF07 - Daniel Markthaler (University of Stuttgart, Institute of Biomaterials and Biomolecular Systems, DE)

Engineering the outer membrane of the purple bacterium Rhodospirillum rubrum for surface display presentation of potential vaccine epitopes


SF3-SF08 - Wisnu Sudjarwo (Biophysics, AT)

Investigating the Influence of Lipid Composition on Lipid Monolayer Behaviour: A Rheological and Hysteresis Study


SF3-SF09 - Nora Müller (Johannes Kepler University, AT)

Characterization of inter-TM interactions within Orai1

10:00 - 10:30

Coffee Break

10:30 - 12:00



Lorenz Aglas University of Salzburg, AT

Fatima Ferreira University of Salzburg, AT

10:30 - 11:00

LS5-IT01 - Rick Maizels (University of Glasgow, GB) Rick Maizels

Parasites and Allergy : Molecular Mediators and Targets for Therapy

11:00 - 11:15

LS5-ST01 - Mario Wenger (University of Salzburg, AT)

Toll-like receptor 4, a major pathway driving Th2 polarization by birch pollen

11:15 - 11:30

LS5-ST02 - Renate Bauer (Paris Lodron University of Salzburg, AT)

Intranasal allergic sensitization to birch pollen extract is reduced in NLRP3-deficient animals

11:30 - 11:45

LS5-ST03 - Natalia Rodrigues Nunes da Silva (Paris Lodron Universität Salzburg, AT)

Computational Identification of Predictive Biomarkers for Responsiveness in Birch Pollen Clinical Trials

11:45 - 12:00

LS5-ST04 - Amin Kraiem (University of Salzburg, AT)

Solubility of the major birch pollen allergen Bet v 1 is a key factor for inducing a pronounced Th2 response in mice

10:30 - 12:00

Disease models & organoids


Gernot Posselt University of Salzburg, AT

Christina Gruber EB Haus Austria, AT

10:30 - 11:00

T5-IT01 - Wilfried Posch (Medical University of Innsbruck, AT) Wilfried Posch

Investigation of infection and protection against inflammatory viral diseases in human 3D cell culture models

11:00 - 11:15

T5-ST01 - Anja Wagner (Medical University Vienna, AT)

Oxford Nanopore sequencing reveals changes in ribosomal RNA modifications in a cellular skin aging model

11:15 - 11:30

T5-ST02 - Leonie Schöftner (University of Salzburg, AT)

Xenografting mouse models to study human cutaneous γδ T cells in health and disease 

11:30 - 11:45

T5-ST03 - Suraj Varkhande (University of Salzburg, AT)

A novel human 3D organotypic skin model to study differentiation of human cutaneous T cells.

11:45 - 12:00

T5-ST04 - Georg Csukovich (Vetmeduni, AT)

The opportunities and uncertainties of apical-out intestinal organoids for in vitro disease modelling.

12:00 - 13:00

Lunch & Poster Session 3

13:00 - 14:30

Cancer biology


Angela Risch University of Salzburg, AT

Richard Greil Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases Oncologic Center, AT

13:00 - 13:30

LS6-IT01 - Wilhelm Palm (German Cancer Research Center (DKFZ), DE) Wilhelm Palm

Extracellular proteins as fuels for cancer cell growth

13:30 - 13:45

LS6-ST01 - Zhigang Rao (Michael Popp Institute, University of Innsbruck, AT)

Zeb1-mediated control of the PUFA/MUFA ratio in EMT-associated ferroptosis sensitivity

13:45 - 14:00

LS6-ST02 - Helene Sieberer (University of Salzburg, AT)

The NLRP3 inhibitor CP-456773 reduces AML cell survival in vitro by downregulation of the FLT3 pathway

14:00 - 14:15

LS6-ST03 - Vincent Z. Braun (Medical University Innsbruck, AT)

Centrosome amplification delays DNA damage-driven blood cancer

14:15 - 14:30

LS6-ST04 - Angelika Lahnsteiner (University of Salzburg, AT)

DNA G-quadruplex structure formation cause differentially methylated CpGs in lung cancer

13:00 - 14:30

Biophysics & signal transduction


Isabella Derler Johannes Kepler Universität Linz, AT

Eva Sevcsik TU Wien, AT

13:00 - 13:30

T6-IT01 - Andrew Plested (Humboldt University Berlin, DE) Andrew Plested

Investigating the activation of CaMKII with light

13:30 - 13:45

T6-ST01 - Hadil Najjar (Johannes Kepler university, AT)

Uncovering inter-TM-domain motions in the Orai1 channel by employing the photocrosslinking unnatural amino acid

13:45 - 14:00

T6-ST02 - Oleksandra Tiapko (Medical University of Graz, AT)

PIP2-governed interaction between VSLD and pore domain potentiates TRPC3 activity

14:00 - 14:15

T6-ST03 - Anita Emmerstorfer-Augustin (Graz University of Technology, AT)

Wsc sensors need to interact with ergosterol for correct function

14:15 - 14:30

T6-ST04 - Aarathy Ravi Sundar Jose Geetha (Paris Lodron University of Salzburg, AT)

So different yet so alike: Investigating the dynamics of gene control intype I vs type II interferon signaling

14:30 - 15:30

Coffee Break & Poster Session 3 & Exhibitor Quiz Drawing I

15:30 - 16:30

ÖGMBT YLSA (Young Life Scientists Austria)


Felix Sternberg Universtiy of Veterinary Medicine Vienna, AT

Natalia Nunes University of Salzburg, AT


YS-IT01 - Rada Hussein (Ludwig Boltzmann Institute for Digital Health and Prevention, AT)

Global Health Informatics: The LBI-DHP’s Perspective 

16:40 - 17:20

Plenary Session 5


Felix Sternberg Universtiy of Veterinary Medicine Vienna, AT

Natalia Nunes University of Salzburg, AT

PL5-PL01 - Paraminder Dhillon (The FEBS Journal, GB) Paraminder Dhillon

How to write a good scientific review article

17:10 - 17:30

Closing Ceremony & Awarding of Best Talk/Poster Prizes & Exhibitor Quiz Drawing II


Social Program

Social Program

Wine & Science
Sept 19, 18:15-21:00

JT22 WineScienceThe ÖGMBT Annual Meeting is also famous for its “Wine & Science” reception (Tuesday evening, September 19), which is included in the registration fee. This welcome reception is held within the industry exhibition area. The exhibitors bring along wine for tasting with the participants and ÖGMBT takes care of cheese and desserts. There are many wine specialties to taste and we have already counted at one of the tastings about 120 different varieties - but don't worry, there are also non-alcoholic offers ;-) Just join and enjoy the networking!


Guided Walking tour around Mönchsberg & Augustinerbräu visit
Sept 20, starting at 18:00

We want to explore the beautiful Salzburg together and let us get to know the history and places during a guided walk (approx. 1,5h) over the Mönchsberg. The tour will be led by professional guides and some locals in smaller groups directly from the meeting place. Together we will then walk to the traditional Augustinerbräu, which is over 400 years old, and end the evening in a convivial atmosphere. The Bräustübl is today the largest beer restaurant in Austria - the beer comes from wooden barrels and is served in stone mugs. We find the matching dishes in the various stalls of the "Schmankerlgang" and look forward to the advice from the locals!

Salzburg Herbst2017 21
@Copyright Tourismus Salzburg Gmbh

Industry Exhibition & Exhibitor Quiz

Industry Exhibition

The life science industry will showcase its products & services within the industry exhibition.



Exhibitor Quiz

JT22 ExhibitorQuizParticipants can take part in the exhibitor quiz and win prizes, by answering the questions at each participating booth. As participant you have to visit the exhibition booths, inform yourself and receive a stamp from the respective booth staff. Only completely filled out quiz-questionnaires can be submitted for the lottery drawing.

On Thursday, September 21, we will have two prize drawings:

  • The prize-drawing for the prizes sponsored by the exhibitors will take place during the last lunch break on Thurs. Sept. 21.
  • The main prizes will be awarded afterwards within the Closing & Prize Ceremony, on Thurs. Sept. 21.


Company workshop

Spatial cell profiling with hyperplex immunofluorescence

Hosted by Lunaphore Technologies SA Lunaphore Technologies

on Wed, Sept.  20 at  14:30-15:30 (during Postersession 2) in HS402

No registration needed, open to all            

Speaker: Muge Akpinar, Field Application Specialist

Multiplex immunofluorescence (mIF) allows the comprehensive analysis of biomarker distribution, which can answer essential questions about the pathophysiology of many disorders and reveal prognostic biomarkers and novel therapeutic targets. We will be diving into how you can overcome spatia’ biology's complexity and technical barriers with Lunaphore’s high-throughput hyperplex solutions. We will show how COMET™, our flagship platform, can detect 40 biomarkers per automated run using your own antibodies clones and standard reagents. This technology robustly and reproducibly produces state-of-the-art whole-tissue images at single-cell resolution. We will also present our new tissue analysis software tailored to support your image analysis workflow by rapidly obtaining precise single-cell data for your custom downstream analysis. We will highlight how to empower your lab with a fast and reliable slide-in data-out approach from immune-oncology to neuro diseases.

Alexander Hanzl, FMI Friedrich Miescher Institute for Biomedical Research, CH

Alexander Hanzl

Alexander Hanzl is a postdoctoral researcher with Nico Thomä at the FMI in Basel. Alex recently completed his PhD in the laboratory of Georg Winter at the Center for Molecular Medicine in Vienna. His thesis revolved around understanding resistance mechanisms in targeted protein degradation as well as employing phenotypic screening to identify novel E3 ligases amendable to this novel therapeutic modality. Prior to joining CeMM in 2017, Alex obtained his MSc with a focus on epigenetics in developmental biology. He originally trained as a chemist and soon moved into chemical biology after his BSc degree.

Matthias Hinterndorfer, CeMM Center for Molecular Medicine, AT

Matthias Hinterndorfer

Matthias Hinterndorfer obtained his PhD from the University of Vienna, working on time-resolved genetic screens to dissect gene functions and regulatory networks under the supervision of Johannes Zuber at the Research Institute of Molecular Pathology (IMP) Vienna. In his PhD, he discovered AKIRIN2 as the factor that regulates the nuclear import of proteasomes in humans and animals, thus being absolutely essential for nuclear protein homeostasis especially in rapidly dividing cells.

He is currently working as postdoctoral fellow with Georg Winter at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, where he is applying phenotypic CRISPR screens to study the genetic machinery underlying chemically induced targeted protein degradation. This work has revealed a novel modality in targeted protein degradation, termed ‘intramolecular glue degraders’.

Carmen Buchrieser, Institut Pasteur, FR

Carmen Buchrieser

Carmen Buchrieser is currently Professor at the Institut Pasteur, Paris, France. She obtained her PhD from the University Salzburg, Austria, conducted postdoctoral trainings at the University of Madison, Wisconsin, USA and at the Institut Pasteur, Paris France. She is heading a research group at the Intitut Pasteur studying bacterial pathogenesis. Her major research interest is to understand how bacteria cause disease: what are the genetic factors conferring bacterial virulence, how do they evolve, what are the mechanisms by which they allow subverting host functions and more generally how do human pathogens emerge. Her team uses Legionella as a model, as these bacteria are at the crossroad between an environmental bacterium (parasite of protozoa) and a human pathogen (replicating in alveolar macrophages).

Christian Schürch, University Hospital Tübingen, DE

Christian Schürch

Dr. Christian M. Schürch is a physician-scientist with over fifteen years of experience in basic and translational cancer immunology research, focusing on hematological malignancies and the tumor microenvironment. He obtained his MD and PhD degrees at the University of Bern, Switzerland, and is board certified in surgical pathology by the Swiss Medical Association. Dr. Schürch was a postdoctoral fellow in Dr. Garry Nolan’s lab at Stanford University, where he worked on high-dimensional tissue imaging of human and murine immune organs and cancer tissues using high-multiplex microscopy. He also worked on the application of computer vision and deep learning to big microscopy imaging datasets. Currently, Dr. Schürch is full professor of pathology, consultant pathologist, and principal investigator at the Institute of Pathology, University Hospital Tübingen. Dr. Schürch’s lab focuses on understanding the role of the tumor microenvironment in (immuno)therapy response in solid and hematological malignancies, including human tumors, in vitro tumor models, and mouse models.

Almut Schulze, DKFZ, DE

Almut Schulze

Almut Schulze, PhD, is a full Professor at the Medical Faculty of the University of Heidelberg and heads the division of Tumor Metabolism and Microenvironment at the German Cancer Research Center. Her research interest is the regulation of cellular metabolic processes by oncogenic signalling pathways and the identification of metabolic vulnerabilities in cancer. She has a specific interest in the transcriptional control of lipid metabolism and its role in cell growth and cancer development. She has published over 70 primary research articles and reviews in the field of signal transduction and cancer metabolism. Prof. Schulze has supervised more than 10 PhD students and 9 post-doctoral fellows. She is member of the American Association of Cancer Research and Associate Editor of Cell Metabolism, Trends in Cancer, Metabolic Engineering and British Journal of Cancer. In 2008, she was elected as EMBO Young Investigator.

Anne C. Conibear, TU Wien, AT

Anne C. Conibear

Anne Conibear completed her B.Sc.(Hons) and M.Sc. in Chemistry (2010) at Rhodes University, South Africa. She then moved to the University of Queensland, Australia for her PhD (2014) with Prof. David Craik, focusing on cyclic disulfide-rich peptides from mammals, the theta-defensins. In 2014, she was awarded an Interdisciplinary Cancer Research postdoctoral fellowship at the University of Vienna and worked with Prof. Christian Becker and Syntab Therapeutics GmbH on targeted immune-stimulating molecules for cancer therapy. She returned to the University of Queensland in 2019 with a UQ Development Fellowship to work on the synthesis and structure of posttranslationally modified proteins. In 2022, she took up a tenure-track Assistant Professor position in Peptide and Protein Chemistry at TU Wien, Austria. Her current research focuses on how posttranslational modifications regulate protein structure and biological function.

Shruti Naik, NYU Langone Health, US

Shruti Naik

Dr. Shruti Naik is an international leader in immunology and stem cell biology. Dr. Naik is an Assistant Professor at NYU Grossman School of Medicine in the Department of Pathology, Ronald O. Perlman Department of Dermatology and Department of Medicine. Her lab studies the crosstalk between immune cells and tissue stem cells in the skin and gut with a focus on 3 major areas of research: 1) inflammatory memory and autoimmunity, 2) tissue repair, and 3) host-microbe interactions. Naik is a strong advocate for increasing diversity in science and promoting the advancement of underrepresented and marginalized groups. She has been recognized for her research and advocacy through numerous accolades including the International Takeda Innovators in Science Award, Pew-Stewart Scholar, Packard Fellowship, NIH Directors Innovator Award and is a NYSCF Robertson Investigator.

Wine & Science Session Description

The ÖGMBT Annual Meeting is also famous for its “Wine & Science” reception (Tuesday evening, September 19), which is included in the registration fee. This welcome reception is held within the industry exhibition area. The exhibitors bring along wine for tasting with the participants and ÖGMBT takes care of cheese and desserts. There are many wine specialties to taste and we have already counted at one of the tastings about 120 different varieties - but don't worry, there are also non-alcoholic offers ;-) Just join and enjoy the networking!

Johanna Gassler, Max Planck Institute of Biochemistry, DE

Johanna Gassler

Johanna Gassler is currently a Wrap-Up postdoctoral researcher in the Department of Totipotency/Tachibana lab at the Max Planck Institute of Biochemistry (MPIB) in Munich, Germany. She obtained her PhD in Molecular Biology in 2023 as a student of the ViennaBioCenter PhD programme at the Institute of Molecular Biotechnology (IMBA) in Vienna, Austria and subsequently MPIB after the lab relocated. During her PhD studies, she investigated chromatin reorganization to totipotency during the murine oocyte-to-zygote transition. She uncovered that the 3D chromatin organization changes during this transition using single-nucleus Hi-C and further identified Nr5a2 as a pioneer factor required for zygotic genome activation.

David Hoi, Institute of Molecular Pathology, AT

David Hoi

David Hoi completed his PhD in Molecular Biology as part of the Vienna Biocenter PhD program at the Institute of Molecular Pathology in the Lab of Tim Clausen where he was studying functional protein degraders (Bacterial PROTACs) as therapeutic strategy against pathogenic Mycobacterium tuberculosis. Within his work he discovered a novel mode of chaperone regulation in the protein quality control pathway of gram positive bacteria using isolated receptor domain proteins to control substrate turnover.

He is continuing his work on novel proximity inducing pharmacological concepts as postdoctoral fellow with Georg Winter at the CeMM Research Center for Molecular Medicine.


Klemens Kremser, University of Natural Resources and Life Sciences, Vienna, AT

Klemens Kremser

Klemens Kremser is a scientist at the University of Natural Resources and Life Science Vienna (BOKU) and the Austrian centre of industrial biotechnology (ACIB). His research at the Institute of Environmental Biotechnology focusses on the development and investigation of bio-based processes for the recycling of different waste materials. Herein, the biological treatment of metal containing waste to exploit artificial ores for urban mining is one of his main research areas. Furthermore, his research focusses on the use and application of extreme acidophilic bacteria in different recycling processes like bioleaching, biogenic acid production and enzymatic plastic depolymerization. He was funded by the European Regional Development Fund with different projects dealing with innovative recycling strategies for ashes and slags and optimization of biogenic sulfuric acid production and is involved in different EU-projects. Mr. Kremser published part of his work in leading scientific journals and presents his research on international conferences.

Saul Villeda, University of California San Francisco, US

Saul Villeda

Dr. Saul Villeda is an Associate Professor in the Department of Anatomy and Endowed Chair in Biomedical Science at the University of California San Francisco and serves as Associate Director of the Bakar Aging Research Institute. He obtained his PhD degree in Neuroscience from Stanford University and started his independent career at the University of California San Francisco as a Sandler Fellow. Dr. Villeda has made the exciting discovery that the aging process in the brain can be reversed by altering levels of circulating factors in blood. Dr. Villeda’s research is best known for the use of innovative heterochronic parabiosis and blood plasma administration approaches to investigate the influence that exposure to young blood-derived or exercise-induced circulating factors has in promoting molecular and cellular changes underlying cognitive rejuvenation.

Ulrich Stelzl, University of Graz, AT

Ulrich Stelzl

Our group is focusing on the analysis of molecular interaction networks with the aim to understand the dynamics of molecular networks underlying cellular processes related to human disease. Experimental functional genomics techniques, e.g. HTP Y2H screening and mass spectrometry, are utilized in combination with biochemical, cell biological and computational methods.

In our work we focus on the systematic analyses of the functional impact of genetic variation and post-translational protein modification on protein-protein interaction, which - as universal protein function - underlies cellular phenotypes. Using deep scanning mutagenesis approaches we bridge the knowledge gap between nucleotide resolution genomics and protein resolution proteomics.

For our record please visit


Alain Hovnanian, INSERM-Imagine Institute, FR

Alain Hovnanian

Alain Hovnanian is professor of Genetics at Necker hospital for sick children at University of Paris, France. He is the director of a research laboratory at the Imagine Institute for genetic diseases in Paris. His laboratory studies rare and severe genetic skin diseases. His laboratory has identified the genetic bases of recessive dystrophic epidermolysis bullosa (RDEB), Darier disease, Netherton syndrome (NS) and a subset of Olmsted syndrome. He has generated several murine models for RDEB and NS and has used transcriptomic and proteomic studies to understand the underlying disease mechanisms. He has developed new targeted therapeutic strategies using gene and cell therapy, small molecules and pharmacological approaches. He recently used repurposed medicines to successfully treat Olmsted syndrome and Pachyonychia Congenita with the oral EGFR inhibitor erlotinib and NS patients with anti-IL17 therapy. Dr Hovnanian is the recipient of the Black Pearl Scientist Award of EURORDIS 2021.

Sebastian Schwaminger, Medical University of Graz, AT

Sebastian Schwaminger

Since February 2022, Sebastian Schwaminger has been working on "Nanomaterials for Drug Delivery" at the Chair of Medical Chemistry at the Otto Loewi Research Center of the Medical University of Graz. After studying Chemical Engineering at the Technical University of Munich (2007-2013), he pursued a doctoral degree in the field of nanotechnology at the Chair of Selective Separation Technology at TU Munich. During research stays in Lund (2011), Dublin (2018), and Ljubljana (2022), Sebastian Schwaminger gained experience with nanoparticulate systems and their interactions with biomolecules and organisms. With an EU-funded Marie Sklodowska Curie Fellowship, he led a research project at the Massachusetts Institute of Technology (2021), where the binding behavior of biomolecules to nanoparticles is electrically controlled. At the Otto Loewi Research Center, he is involved in the synthesis and characterization of nanomaterials in the field of circulatory and vascular research. His focus is on the use of magnetic nanomaterials for medical and pharmaceutical applications. In particular, iron oxide-based nanomaterials are to be used to enable magnetically controlled drug transport.

Jörg Menche, University of Vienna, AT

Jörg Menche

Jörg Menche studied physics in Germany and Brazil and obtained a PhD at the Max Planck Institute for Colloids and Interfaces in 2010. He worked as a postdoc at Northeastern University and Harvard Medical School in Boston, before starting his own research group at the CeMM Research Center for Molecular Medicine in Vienna in 2015. In 2020 he became full professor at the University of Vienna where he holds a shared appointment at the Center for Molecular Biology (Max Perutz Labs) and the Faculty of Mathematics. His interdisciplinary team combines backgrounds ranging from biology and bioinformatics to medicine, physics, mathematics & arts. The broad ambition of his group is to use tools and concepts from network theory to elucidate the complex machinery of interacting molecules that constitutes the basis of (patho-)physiological states. Major areas of interest are network-based approaches to rare diseases, understanding the basic principles of how perturbations of biological systems influence each other and developing novel Virtual Reality (VR) based technologies for analyzing large genomic data.

Guided walk & Beer garden Session Description

We want to explore the beautiful Salzburg together and let us get to know the history and places during a guided walk (approx. 1,5h) over the Mönchsberg. The tour will be led by professional guides and some locals in smaller groups directly from the meeting place. Together we will then walk to the traditional Augustinerbräu, which is over 400 years old, and end the evening in a convivial atmosphere. The Bräustübl is today the largest beer restaurant in Austria - the beer comes from wooden barrels and is served in stone mugs. We find the matching dishes in the various stalls of the "Schmankerlgang" and look forward to the advice from the locals!

Pieter Vader, University Medical Center Utrecht, NL

Pieter Vader

Pieter Vader graduated in Chemistry (B.Sc., 2005) and Drug Innovation (M.Sc., 2007) from the University of Utrecht. He earned his PhD degree in 2012 from the University of Utrecht on the subject of targeted delivery of siRNA to inhibit tumor angiogenesis.

From 2012 to 2014, Pieter was employed as a (senior) postdoctoral fellow at the University of Oxford, UK, in the lab of Prof. Matthew Wood, supported by a NWO Rubicon fellowship. The research topic was development of small RNA-loaded extracellular vesicles for targeted delivery.

In 2014 he moved back to The Netherlands to continue his work at the University Medical Center Utrecht. Currently, he is Associate Professor at CDL Research and at the Department of Experimental Cardiology. His main research interests are in the field of therapeutic applications of extracellular vesicles, including unraveling the mechanisms underlying extracellular vesicle-mediated cargo transfer. His research has been supported by a NWO Veni Grant (2014), ERC Starting Grant (2019), Dutch Heart Foundation Dekker Senior Scientist Grant (2019), and NWO Vidi Grant (2020). In 2021, Pieter was awarded the Prix Galien Research Award for his work on drug delivery.

Rick Maizels, University of Glasgow, GB

Rick Maizels

Professor Rick Maizels is at the Wellcome Centre for Integrative Parasitology in the University of Glasgow's School of Infection and Immunity.  He is an immunologist interested in fundamental questions of how parasites suppress the mammalian immune system, primarily for their own survival but in so doing, also dampen inflammatory disorders, particularly allergy and IBD.  His work aims to discover novel immunomodulators from parasites that may be useful in suppressing inflammation and disease, and to develop new vaccine strategies that can lead to clearance of these very prevalent parasites. Rick moved to the University of Glasgow in 2016; until 2015 he held the Chair of Zoology at the University of Edinburgh, and was previously Professor of Parasite Immunology at Imperial College London. Prior to this, he held positions at the National Institute for Medical Research in London, as well as UCLA and California Institute of Technology. He was elected Fellow of the Royal Society of Edinburgh in 2002, and a Fellow of the Academy of Medical Sciences in 2018.

Wilfried Posch, Medical University of Innsbruck, AT

Wilfried Posch

Wilfried Posch is Associate Professor of Emerging Infectious Diseases at the Medical University of Innsbruck, Innsbruck, Austria. Wilfried studied Molecular Biology and the focus of his PhD was the characterization of host-pathogen interactions. During his research stays at the University College London, London, UK and at the INSERM UMR-S945 in Paris, France, he could further develop his knowledge in infection biology, inflammation and immune regulation. In 2018, he received his Habilitation in Immunology and established a research group at the Institute of Hygiene and Medical Microbiology. He and his team have been working on developing novel strategies for investigating viral infections using human 3D cell culture models. Due to his ample expertise in T cell immunity, the group is currently also interested in studying adaptive immune responses within 3D cell culture systems.

Wilhelm Palm, German Cancer Research Center (DKFZ), DE

Wilhelm Palm

Wilhelm Palm investigates the interplay between signaling and metabolism in mammalian cells. A main focus of his lab are cellular adaptations to environmental stresses, which are exploited by cancer cells to survive and grow in nutrient-poor tumors. Wilhelm Palm has conducted his master research with Titia de Lange at The Rockefeller University, his PhD with Suzanne Eaton at the MPI of Molecular Cell Biology and Genetics, and his postdoc with Craig Thompson at Memorial Sloan Kettering Cancer Center. He currently is a group leader at the German Cancer Research Center (DFKZ) in Heidelberg.

Andrew Plested, Humboldt University Berlin, DE

Andrew Plested

Andrew Plested trained as a physicist but moved into biology for a PhD on anaesthetic mechanisms with Nick Franks and Bill Lieb at Imperial College London, which he completed in 2002. After this he worked on ion channel biophysics and structural biology with David Colquhoun at UCL and Mark Mayer at the NIH, USA. Following a junior group at the FMP in Berlin (2008-2017), he took up a professorship at the Humboldt University Berlin. His main research interests are glutamate receptors and the excitatory synapses in which they reside. He aims to understand the molecular basis of synaptic transmission, and to develop methods to observe and alter neuronal activity. To achieve this, his lab uses a range of biophysical techniques, complemented by fluorescence microscopy and chemical biology. Recently, he has extend these studies to the enzyme CaMKII. His lab uses a range of experimental systems, from single channel recording and single molecule imaging to neurophysiology in brain slices.

Paraminder Dhillon, The FEBS Journal, GB

Paraminder Dhillon

Paraminder Dhillon is a scientific editor with over a decade of experience in handling original research and review articles submitted at high-quality biomedical journals. She received her PhD from the University of Cambridge for studying aspects of flagellar type III secretion in Salmonella typhimurium, and began her editorial career in 2012 as Assistant Editor at the BMC journal Genome Medicine. After a brief stint as an editor in the science education division at Cambridge University Press, she returned to STM journal publishing in 2013 as Scientific Editor of Disease Models & Mechanisms (DMM), an Open Access journal published by the Company of Biologists. In 2018, she joined The FEBS Journal, based in Cambridge, UK, as its Managing Editor and is now Senior Managing Editor at the journal. The FEBS Journal is the flagship journal of FEBS Press and publishes research and reviews across the breadth of the molecular, cellular and biochemical life sciences.

Sponsors of 15th ÖGMBT Annual Meeting

  • 10x320.jpg

  • AKOYA 440x252 white background

  • analytik jena logo

  • bartelt logo 110x63px

  • LOGO BioCat 440x252

  • biolab

  • biomedica logo small 300dpi

  • Biozym110x63

  • BMAW Logo 330px

  • Logo BOKU CF Allgemein

  • EPPENDORF 110x63

  • eurofins110

  • FEBSJournal

  • FEBs openbio

  • GenScriptLogo 4725x1500

  • Logo greiner bioone 2c RGB dcf2d90b f755 4fa2 b7f0 6293b149abd7

  • IDT Logo 1430x756 white background


  • Labconsulting 110x63

  • landsbg

  • licor logo blue

  • Lunaphore Technologies   Logotype1

  • 02 MIC Logo Austria OrangeGrey RGB 440x252

  • MolecularDevices Logo 2200x1260

  • logo mp bleu HQ CMJNtrans




  • NEB GmbH with inspired claim square 4c 4

  • novogene 880x504


  • 1 pol

  • PromegaLogo Sol

  • Logo Ptg Main

  • logo sarstedt 440x252

  • servoLAB110x63

  • shimadzu 110x63


  • slas 440x252

  • stratec logo 4c

  • SzSc Logo 4C kompakt 10cm150dpi

  • targetmol logo

  • Tecan 336px

  • THP logo rgb 300 1changed

  • World Courier logo 110x63

  • zeiss logo tagline cmyk 1

next prev